FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:1456-1457 October 4, 2007 Number 14 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

By Margaret L. Eaton and Donald Kennedy. 155 pp. Baltimore, Johns Hopkins University Press, 2007. $35. ISBN 978-0-8018-8526-6.

After publication of the Belmont Report in 1978, it became common to distinguish research, in which human subjects receive the full set of protections provided by the U.S. Common Rule (45 CFR 46), from innovative medical care, in which they do not. This distinction faces two major difficulties: it relies on a sharp differentiation between research and innovative medical care without a proper basis for drawing it, and it does not address the question of what sort of protections are appropriate for patients who receive innovative medical care. This book represents the thinking of a group that was convened by . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.